These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 33200690)
21. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters. Di Daniel E; Cheng L; Maycox PR; Mudge AW Mol Cell Neurosci; 2006; 32(1-2):27-36. PubMed ID: 16531065 [TBL] [Abstract][Full Text] [Related]
22. Thiadiazine-thiones as inhibitors of leishmania pteridine reductase (PTR1) target: investigations and in silico approach. Shtaiwi A J Biomol Struct Dyn; 2024 Oct; 42(16):8588-8597. PubMed ID: 37578348 [TBL] [Abstract][Full Text] [Related]
23. Computational study to discover potent phytochemical inhibitors against drug target, squalene synthase from Wadanambi PM; Mannapperuma U Heliyon; 2021 Jun; 7(6):e07178. PubMed ID: 34141935 [TBL] [Abstract][Full Text] [Related]
24. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase. Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242 [TBL] [Abstract][Full Text] [Related]
25. sll1981, an acetolactate synthase homologue of Synechocystis sp. PCC6803, functions as L-myo-inositol 1-phosphate synthase. Chatterjee A; Dastidar KG; Maitra S; Das-Chatterjee A; Dihazi H; Eschrich K; Majumder AL Planta; 2006 Jul; 224(2):367-79. PubMed ID: 16453101 [TBL] [Abstract][Full Text] [Related]
33. Valproate regulates inositol synthesis by reducing expression of myo-inositol-3-phosphate synthase. Case KC; Beltman RJ; Pflum MKH; Greenberg ML Sci Rep; 2023 Sep; 13(1):14844. PubMed ID: 37684289 [TBL] [Abstract][Full Text] [Related]
34. Generation of myo-inositol-auxotrophic Leishmania mexicana mutants by targeted replacement of the myo-inositol-1-phosphate synthase gene. Ilg T Mol Biochem Parasitol; 2002 Mar; 120(1):151-6. PubMed ID: 11849714 [No Abstract] [Full Text] [Related]
35. Dual-target drugs against Leishmania donovani for potential novel therapeutics. Bora K; Sarma M; Kanaujia SP; Dubey VK Sci Rep; 2023 Oct; 13(1):18363. PubMed ID: 37884555 [TBL] [Abstract][Full Text] [Related]
36. Biophysical and modeling-based approach for the identification of inhibitors against DOHH from Leishmania donovani. Katiki M; Sharma M; Neetu N; Rentala M; Kumar P Brief Funct Genomics; 2023 Apr; 22(2):217-226. PubMed ID: 35809341 [TBL] [Abstract][Full Text] [Related]
37. Homology Modeling, Sakyi PO; Broni E; Amewu RK; Miller WA; Wilson MD; Kwofie SK Front Cell Infect Microbiol; 2022; 12():859981. PubMed ID: 35719359 [TBL] [Abstract][Full Text] [Related]
38. N-acetylglucosamine-phosphatidylinositol de-N-acetylase as a novel target for probing potential inhibitor against Kumar M; Tripathi MK; Gupta D; Kumar S; Biswas NR; Ethayathulla AS; Kaur P J Biomol Struct Dyn; 2023 Mar; 41(5):1904-1918. PubMed ID: 35014594 [No Abstract] [Full Text] [Related]
39. Human 1-D-myo-inositol-3-phosphate synthase is functional in yeast. Ju S; Shaltiel G; Shamir A; Agam G; Greenberg ML J Biol Chem; 2004 May; 279(21):21759-65. PubMed ID: 15024000 [TBL] [Abstract][Full Text] [Related]